Amgen Can't Ditch Regeneron's Bundling Antitrust Suit

By Bonnie Eslinger · April 11, 2025, 9:58 PM EDT

A Delaware federal judge on Thursday denied Amgen's bid to toss antitrust litigation brought by Regeneron accusing its rival of using a bundling scheme to increase the sales of its cholesterol...

To view the full article, register now.

Documents

Case Information

Case Title

Regeneron Pharmaceuticals, Inc. v. Amgen Inc.

Case Number

1:22-cv-00697

Court

Delaware

Nature of Suit

Anti-Trust

Date Filed

May 27, 2022